4,7-Dihydro-2-isopropyl-1,3-dioxepin → HCID 20392493, compound
Reaction equation
[CH2:1]([C:8]1O[C:10]([O:14]CC)=[C:11]([CH3:13])[N:12]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[CH:17]([CH:20]1[O:26][CH2:25][CH:24]=[CH:23][CH2:22][O:21]1)([CH3:19])[CH3:18]>>[CH:17]([CH:20]1[O:26][CH2:25][C:24]2[C:8]([CH2:1][C:2]3[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=3)=[N:12][C:11]([CH3:13])=[C:10]([OH:14])[C:23]=2[CH2:22][O:21]1)([CH3:19])[CH3:18]Participants
3
Conditions
- Temperature
- 180 °C
Procedure
A mixture of 12.6 g (60 millimoles) of 2-benzyl-4-methyl-5-ethoxy-oxazole and 42.6 g (300 millimoles) of 2-isopropyl-4,7-dihydro-1,3-dioxepine is heated for 5 hours at 180° C. On cooling the mixture in an ice bath, 4.2 g of 3-isopropyl-6-benzyl-8-methyl-1,5-dihydro-[1,3]dioxepino[5,6-c]pyridin-9-ol crystallize out. A further 2.0 are obtained by evaporating the mother liquor, partitioning the residue between methylene chloride and dilute sodium hydroxide solution and neutralizing the alkaline phase. Recrystallization from ethyl acetate gives a pure product, of melting point 193°-194° C.
Workup
- temperatureOn cooling the mixture in an ice bath
- custom4.2 g of 3-isopropyl-6-benzyl-8-methyl-1,5-dihydro-[1,3]dioxepino[5,6-c]pyridin-9-ol crystallize out
- customA further 2.0 are obtained
- customby evaporating the mother liquor
- custompartitioning the residue between methylene chloride and dilute sodium hydroxide solution
- customRecrystallization from ethyl acetate
- customgives a pure product
Sources & evidence
- ORD record
- ord-ade8e962637741839edf526e2e4c9229
- Source dataset
- uspto-grants-1979_09
- Patent number
- US04168379
Reaction notes
Loading…